Please login to the form below

Not currently logged in
Email:
Password:

Naxitamab

This page shows the latest Naxitamab news and features for those working in and with pharma, biotech and healthcare.

Y-mAbs files breakthrough neuroblastoma drug in US

Y-mAbs files breakthrough neuroblastoma drug in US

The BLA will cover the use of naxitamab in combination with GM-CSF – a white blood cell stimulating drug – in relapsed/refractory high-risk neuroblastoma patients. ... Y-mAbs reported new results from its main phase 3 naxitamab study at the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics